StockDuty Jun 24, 2026 05:20 PM ET
CatalystEarnings

$OKTA — AVOID 📊 | 6 MONTHS THESIS

OKTA
$124.28
+4.21%
$OKTA — AVOID 📊 | 6 MONTHS THESIS 🎯 FQ1 FY2027 (ends Apr) | reported May 28 | Rev $765M | EPS $0.41 vs $0.31 🟢 | Margin 7.3% 💡 Consensus EPS of $0.31 severely underestimated profitability; actual $0.41 beat by 32%. However, the stock has already repriced post-earnings, and the gap is now closed. Forward expectations may be too optimistic. 📉 Reward/risk: 1.0:1 🏢 Business Quality: 7 — strong platform with sticky revenue, but high R&D spending and moderate growth limit margin expansion./10 📊 Valuation: rich — trailing P/E 76x, EV/Revenue 27x, FCF yield 1.3%; compared to peers like CRWD (90x P/E with 30% revenue growth), OKTA is relatively cheaper... 🔮 Catalyst: FQ2 FY2027 earnings (approx late August 2026) 💰 Entry: $125.09, stop $110, target $140 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/OKTA0627
🎯 FQ1 FY2027 (ends Apr) | reported May 28 | Rev $765M | EPS $0.41 vs $0.31 🟢 | Margin 7.3%
Sources
pipeline